Dr Tamer Al-Sayed

Dr Al-Sayed specialises in internal medicine, particularly the emergency aspects and its interface with critical care medicine. Dr Al-Sayed currently holds the post of Consultant in Acute Medicine with a renal subspecialty at the Wythenshawe Hospital, part of the Manchester University Teaching Hospitals NHS Foundation Trust. Dr Al-Sayed is also an Honorary Consultant in Acute Medicine with a renal subspecialty at The Christie NHS Foundation Trust where he is also the Acute Kidney Injury (AKI) Lead.

Dr Al-Sayed has an interest in renal disorders and acute kidney injury in particular, risk recognition, early detection and intervention in both oncology and non-oncology patients. He has a further interest in electrolyte and acid base disturbances, particularly in patients receiving systemic anticancer chemotherapy.

Dr Al-Sayed is a Royal College of Physicians (RCOP) Tutor at the Wythenshawe Hospital and previous Lead for final year students. He has both undergraduate and postgraduate teaching and training commitments.

Dr Al-Sayed's main research interests are in AKI in particular looking at the development of biomarkers in the cancer treated population. He has done work with the Head & Neck Cancer Group at The Christie NHS Foundation Trust on ways to mitigate the development of AKI in patients treated with cisplatin chemotherapy and also who develop radiation induced mucositis.

3

4